Literature DB >> 5316953

A co-operative evaluation of test systems used to assay tuberculosis vaccines.

E H Wiegeshaus, G Harding, D McMurray, A A Grover, D W Smith.   

Abstract

The results of research on the immunogenicity of experimental mycobacterial vaccines are characterized by a remarkable lack of agreement about which substances are most immunogenic. The disagreement has usually been attributed to the differences in the methods of preparing the vaccines. An alternative hypothesis is that the conflicting results are a product of the different methods used to assess the potency of the vaccines.To determine if the method by which a vaccine is tested is a major factor contributing to the disagreement, an experiment was conducted in which a series of five different vaccines was distributed to each of nine participating laboratories. Each investigator evaluated the potency of the vaccines in one or more animal models of his own choosing. This in effect held the method of vaccine preparation constant while permitting all other variables to change.The ranking of the five vaccines was random, thus demonstrating that the method by which a vaccine is tested influences the apparent potency of a vaccine. These results cast doubt on the conclusions about the relative potency of tuberculosis vaccines evaluated by different methods.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5316953      PMCID: PMC2427965     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  Immunogenicity and allergenioity in guinea pigs of a defatted mycobacterial vaccine and its fractions.

Authors:  G B FREGNAN; D W SMITH
Journal:  Am Rev Respir Dis       Date:  1963-06

2.  Preparation and properties of a freeze-dried B.C.G. vaccine of increased stability.

Authors:  J UNGAR; P W MUGGLETON; J A DUDLEY; M I GRIFFITHS
Journal:  Br Med J       Date:  1962-10-27

Review 3.  Nonliving immunogenic substances of Mycobacteria.

Authors:  D W Smith; A A Grover; E Wiegeshaus
Journal:  Bibl Tuberc       Date:  1968

4.  Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.

Authors:  C E Palmer; M W Long
Journal:  Am Rev Respir Dis       Date:  1966-10
  4 in total
  8 in total

Review 1.  Immunity to tuberculosis from the perspective of pathogenesis.

Authors:  E Wiegeshaus; V Balasubramanian; D W Smith
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

Review 2.  Genetic vaccination against tuberculosis.

Authors:  D B Lowrie; C L Silva; R E Tascon
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Comment on "tuberculosis studies in Muscogee County, Georgia".

Authors:  P D Hart; I Sutherland
Journal:  Public Health Rep       Date:  1977 May-Jun       Impact factor: 2.792

4.  Preservation of mycobacteria: 100 percent viability of suspensions stored at -70 C.

Authors:  T H Kim; G P Kubica
Journal:  Appl Microbiol       Date:  1973-06

5.  Evaluation of BCG vaccination among Puerto Rican children.

Authors:  G W Comstock; V T Livesay; S F Woolpert
Journal:  Am J Public Health       Date:  1974-03       Impact factor: 9.308

Review 6.  Present knowledge of immunization against tuberculosis.

Authors:  H G Dam; K Toman; K L Hitze; J Guld
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

7.  Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis.

Authors:  Ajay Grover; Jolynn Troudt; Kimberly Arnett; Linda Izzo; Megan Lucas; Katie Strain; Christine McFarland; Yper Hall; David McMurray; Ann Williams; Karen Dobos; Angelo Izzo
Journal:  Tuberculosis (Edinb)       Date:  2011-10-01       Impact factor: 3.131

8.  Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination.

Authors:  G W Comstock; S F Woolpert; V T Livesay
Journal:  Public Health Rep       Date:  1976 May-Jun       Impact factor: 2.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.